SCHEMBL7988680

SCHEMBL7988680

COCOc1c(C(C)(C)C)cc(-c2nc3ncn(Cc4ccccc4)c3c(=O)[nH]2)cc1C(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ KMT2A Q03164 2/20 0.45
▸ GAA P10253 1/20 0.41
▸ BRD4 O60885 1/20 0.37
▸ MEN1 O00255 1/20 0.35
▸ PARN O95453 1/20 0.35
▸ CNOT7 Q9UIV1 1/20 0.35
▸ PNP P00491 1/20 0.35
▸ P2RX7 Q99572 3/20 0.35
▸ ADORA3 P0DMS8 2/20 0.35
▸ ADORA2B P29275 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984961 0.88 HPGD (0.48) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7986235 0.86 SMN1; SMN2 (0.52) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7988685 0.85 PARN (0.41) HPGDSMN1; SMN2ALDH1A1GAAPARN
SCHEMBL8056958 0.83 SMN1; SMN2 (0.52) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7985355 0.81 GAA (0.56) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7985321 0.80 SMN1; SMN2 (0.55) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7988683 0.80 GAA (0.38) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7975265 0.79 SMN1; SMN2 (0.61) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7985230 0.78 ALDH1A1 (0.53) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7974486 0.78 SMN1; SMN2 (0.50) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 — — US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 — — EP disclosed
Send feedback